294 related articles for article (PubMed ID: 32425934)
1. Platelet Toll-Like Receptors Mediate Thromboinflammatory Responses in Patients With Essential Thrombocythemia.
Marín Oyarzún CP; Glembotsky AC; Goette NP; Lev PR; De Luca G; Baroni Pietto MC; Moiraghi B; Castro Ríos MA; Vicente A; Marta RF; Schattner M; Heller PG
Front Immunol; 2020; 11():705. PubMed ID: 32425934
[TBL] [Abstract][Full Text] [Related]
2. Regulation of platelet responses triggered by Toll-like receptor 2 and 4 ligands is another non-genomic role of nuclear factor-kappaB.
Rivadeneyra L; Carestia A; Etulain J; Pozner RG; Fondevila C; Negrotto S; Schattner M
Thromb Res; 2014 Feb; 133(2):235-43. PubMed ID: 24331207
[TBL] [Abstract][Full Text] [Related]
3. Platelet mass cytometry reveals dysregulation of prothrombotic pathways in essential thrombocythemia.
Dill V; Kirmes K; Han J; Klug M; Rosenbaum M; Viggiani G; von Scheidt M; List M; Herhaus P; Ruland J; Bassermann F; Laugwitz KL; Götze KS; Jost PJ; Jilg S; Bloxham CJ; Raake PWJ; Bernlochner I; Bongiovanni D
Platelets; 2024 Dec; 35(1):2358244. PubMed ID: 38845541
[TBL] [Abstract][Full Text] [Related]
4. The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera.
Michiels JJ; Berneman Z; Schroyens W; Finazzi G; Budde U; van Vliet HH
Semin Thromb Hemost; 2006 Sep; 32(6):589-604. PubMed ID: 16977569
[TBL] [Abstract][Full Text] [Related]
5. Increased platelet and leukocyte activation as contributing mechanisms for thrombosis in essential thrombocythemia and correlation with the JAK2 mutational status.
Arellano-Rodrigo E; Alvarez-Larrán A; Reverter JC; Villamor N; Colomer D; Cervantes F
Haematologica; 2006 Feb; 91(2):169-75. PubMed ID: 16461300
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor expression and functional behavior in platelets from patients with systemic lupus erythematosus.
Baroni Pietto MC; Glembotsky AC; Lev PR; Marín Oyarzún CR; De Luca G; Gomez G; Collado MV; Charó N; Cellucci AS; Heller PG; Goette NP; Marta RF
Immunobiology; 2024 Jan; 229(1):152782. PubMed ID: 38159527
[TBL] [Abstract][Full Text] [Related]
7. Immune versus thrombotic stimulation of platelets differentially regulates signalling pathways, intracellular protein-protein interactions, and alpha-granule release.
Rex S; Beaulieu LM; Perlman DH; Vitseva O; Blair PS; McComb ME; Costello CE; Freedman JE
Thromb Haemost; 2009 Jul; 102(1):97-110. PubMed ID: 19572074
[TBL] [Abstract][Full Text] [Related]
8. Clinical and laboratory features, pathobiology of platelet-mediated thrombosis and bleeding complications, and the molecular etiology of essential thrombocythemia and polycythemia vera: therapeutic implications.
Michiels JJ; Berneman Z; Van Bockstaele D; van der Planken M; De Raeve H; Schroyens W
Semin Thromb Hemost; 2006 Apr; 32(3):174-207. PubMed ID: 16673274
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of platelets and platelet inhibition by ticagrelor on TLR2- and TLR4-mediated inflammatory responses.
Tunjungputri RN; van der Ven AJ; Riksen N; Rongen G; Tacke S; van den Berg TN; Fijnheer R; Gomes ME; Dinarello CA; van de Veerdonk FL; Gasem MH; Netea MG; Joosten LA; de Groot PG; de Mast Q
Thromb Haemost; 2015 May; 113(5):1035-45. PubMed ID: 25716539
[TBL] [Abstract][Full Text] [Related]
10. Platelet turnover, coagulation factors, and soluble markers of platelet and endothelial activation in essential thrombocythemia: relationship with thrombosis occurrence and JAK2 V617F allele burden.
Arellano-Rodrigo E; Alvarez-Larrán A; Reverter JC; Colomer D; Villamor N; Bellosillo B; Cervantes F
Am J Hematol; 2009 Feb; 84(2):102-8. PubMed ID: 19105233
[TBL] [Abstract][Full Text] [Related]
11. Platelet Toll-like receptor expression and activation induced by lipopolysaccharide and sepsis.
Claushuis TAM; Van Der Veen AIP; Horn J; Schultz MJ; Houtkooper RH; Van 't Veer C; Van Der Poll T
Platelets; 2019; 30(3):296-304. PubMed ID: 29528268
[TBL] [Abstract][Full Text] [Related]
12. Differential roles of Toll-like receptors in the elicitation of proinflammatory responses by macrophages.
Jones BW; Heldwein KA; Means TK; Saukkonen JJ; Fenton MJ
Ann Rheum Dis; 2001 Nov; 60 Suppl 3(Suppl 3):iii6-12. PubMed ID: 11890657
[TBL] [Abstract][Full Text] [Related]
13. Platelet Toll-like receptor (TLR) expression and TLR-mediated platelet activation in acute myocardial infarction.
Hally KE; La Flamme AC; Larsen PD; Harding SA
Thromb Res; 2017 Oct; 158():8-15. PubMed ID: 28783513
[TBL] [Abstract][Full Text] [Related]
14. The effects of aspirin and ticagrelor on Toll-like receptor (TLR)-mediated platelet activation: results of a randomized, cross-over trial.
Hally KE; La Flamme AC; Harding SA; Larsen PD
Platelets; 2019; 30(5):599-607. PubMed ID: 29869943
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of Toll-like receptor 2 in human platelets induces a thromboinflammatory response through activation of phosphoinositide 3-kinase.
Blair P; Rex S; Vitseva O; Beaulieu L; Tanriverdi K; Chakrabarti S; Hayashi C; Genco CA; Iafrati M; Freedman JE
Circ Res; 2009 Feb; 104(3):346-54. PubMed ID: 19106411
[TBL] [Abstract][Full Text] [Related]
16. Platelet toll-like receptors in thromboinflammation.
D' Atri LP; Schattner M
Front Biosci (Landmark Ed); 2017 Jun; 22(11):1867-1883. PubMed ID: 28410150
[TBL] [Abstract][Full Text] [Related]
17. The toll-like receptor 2/1 (TLR2/1) complex initiates human platelet activation via the src/Syk/LAT/PLCγ2 signalling cascade.
Fälker K; Klarström-Engström K; Bengtsson T; Lindahl TL; Grenegård M
Cell Signal; 2014 Feb; 26(2):279-86. PubMed ID: 24240055
[TBL] [Abstract][Full Text] [Related]
18. Human cytomegalovirus-platelet interaction triggers toll-like receptor 2-dependent proinflammatory and proangiogenic responses.
Assinger A; Kral JB; Yaiw KC; Schrottmaier WC; Kurzejamska E; Wang Y; Mohammad AA; Religa P; Rahbar A; Schabbauer G; Butler LM; Söderberg-Naucler C
Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):801-9. PubMed ID: 24558109
[TBL] [Abstract][Full Text] [Related]
19. Comparison of coated-platelet levels in patients with essential thrombocythemia with and without hydroxyurea treatment.
Reményi G; Szász R; Debreceni IB; Szarvas M; Batár P; Nagy B; Kappelmayer J; Udvardy M
Platelets; 2013; 24(6):486-92. PubMed ID: 23216455
[TBL] [Abstract][Full Text] [Related]
20. Agonists of toll-like receptor (TLR)2 and TLR4 are unable to modulate platelet activation by adenosine diphosphate and platelet activating factor.
Ward JR; Bingle L; Judge HM; Brown SB; Storey RF; Whyte MK; Dower SK; Buttle DJ; Sabroe I
Thromb Haemost; 2005 Oct; 94(4):831-8. PubMed ID: 16270639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
